Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Waltraud Leisgang
Observed name:
W. Leisgang
Institutions:
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Universitätsklinikum Erlangen
Observed institutions:
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Universitätsklinikum Erlangen
OpenAlex ID:
A5074263152
Mage-3 and Influenza-Matrix Peptide-Specific Cytotoxic T Cells Are Inducible in Terminal Stage HLA-A2.1+ Melanoma Patients by Mature Monocyte-Derived Dendritic Cells
2000
·
Beatrice Schuler-Thurner
, Detlef Dieckmann
, et al.
·
The Journal of Immunology
·
201
PDF
A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use
2000
·
Bernadette Feuerstein
, Thomas G Berger
, et al.
·
Journal of Immunological Methods
·
159
Eosinophilic Count as a Biomarker for Prognosis of Melanoma Patients and Its Importance in The Response to Immunotherapy
2017
·
Alvaro Moreira
, Waltraud Leisgang
, et al.
·
Immunotherapy
·
150
Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg
2013
·
Andreas S. Baur
, Manfred B. Lutz
, et al.
·
Blood
·
64
Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab
2017
·
C. Brüggemann
, M. C. Kirchberger
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
19
Association of PD-L1 expression in melanoma with response and prognosis to ipilimumab.
2015
·
Caroline Brueggemann
, Benjamin Weide
, et al.
·
Journal of Clinical Oncology
·
1
Show more works
View as search
Works count:
7
Citation count:
594
H-index:
5
I10-index:
5
Year
Topic
Type